Shares of Eli Lilly (NYSE: LLY) rose to a new all-time high on Tuesday, following upbeat analyst remarks. A medical ...

Eli Lilly (NYSE: LLY) stock has been rallying in recent months, taking off from around $850 in late April to more than $1,200 ...

The stock has surged 160% over the past three years. Meanwhile, two key drugs could continue driving rampant growth.

When it comes to dividend stocks, no other sector has been more reliable than the healthcare sector. No matter the economic ...

CNBC's Angelica Peebles reports on Eli Lilly's stock performance. Got a confidential news tip? We want to hear from you. Sign ...

Drug stocks got hit hard on Monday in what Jim Cramer called a “vicious rotation,” and the selloff looked like the usual crowded-trade unwind. Investors decided the Mounjaro story was played out. On ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Lilly offers investors safety and growth.

Dave Ricks steered the 150-year-old drug giant to a $1 trillion market cap. Can he defeat pharma’s boom and bust cycle?

Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two ...

Eli Lilly's new top dealmaker explains how the company changed its approach to M&A now that it's the most valuable pharmaceutical company in the world.

In the latest China pharmaceutical industry collaboration pact with a global drug leader, Abbisko said today it will work ...